baber/WOPTO huggingface dataset:
Patent AU-687019-B2 (AU)
Title: A collapsible mop pad holder
Inventor: RIMER ALF
IPC: A47L13/258
Filed: 1993-11-05
Granted: 1998-02-19
Abstract: PCT No. PCT/DK93/00360 Sec. 371 Date Jun. 28, 1995 Sec. 102(e) Date Jun. 28, 1995 PCT Filed Nov. 5, 1993 PCT Pub. No. WO94/09692 PCT Pub. Date May 11, 1994A collapsible mop pad holder including a body member, at least first and second wing parts each pivotally connected to the body member so as to be pivotable between an operative position in which the body member and the wing part define a surface for supporting a mop pad, and an inoperative position in which the wing part depends from the body part, first and second locking means for locking the first and second wing parts, respectively, in relation to the body member in the operative positions of the wing parts, each of said first and second locking means comprising a first latch member moveable between a locking position, in which it is in locking engagement with the respective wing part in its operative position, and a releasing position, a locking element having the first latch members arranged thereon being moveably mounted on the body member so as to be moveable in relation thereto, and first actuating means for moving the locking element so as to move the first latch members between their locking and releasing positions. A combination of a mop pad holder and a mop pad, and the mop pad holder and a mop pad for use in such a combination is further disclosed.
Patent AU-742638-B2 (AU)
Title: Improved chondrogenic differentiation of human mesenchymal stem cells
Inventor: PITTENGER MARK F
IPC: A61K38/00
Filed: 1997-12-05
Granted: 2002-01-10
Abstract: Disclosed are a composition of chemically defined components having elevated levels of simple sugars which support the enhanced in vitro chondrogenesis of mesenchymal progenitor cells, a method for in vitro chondrogenic induction of such progenitor cells and a method of forming human chondrocytes in vitro from such progenitor cells.
Patent AU-603983-B2 (AU)
Title: Expression of factor vii and ix activities in mammalian cells
Inventor: HAGEN FREDERICK S
IPC: C12N5/00
Filed: 1986-04-16
Granted: 1990-12-06
Abstract: DNA construct contains a nucleotide sequence (I) encoding a protein, which, on activation, has the same biological activity for blood coagulation as Factor VIIa. (I) codes at least partially for Factor VII and comprises a first sequence (Ia) encoding a calcium binding domain, joined to a second sequence downstream of (Ia), which encodes a catalytic domain for the serine protease activity of Factor VIIa. (Ia) comprises a gene encoding Factor VII, Factor IX, Factor X, Protein C, prothrombin or Protein S. - A recombinant plasmid is provided which includes a promoter followed downstream by (I), which is followed downstream by a polyadenylation signal.
Patent AU-688683-B2 (AU)
Title: Leaching process
Inventor: LANDFORS JOHAN
IPC: D21C11/04
Filed: 1996-07-08
Granted: 1998-03-12
Abstract: An increasing problem with the pulping chemical recovery system, is the presence of chloride and potassium in the recovery boiler. Chloride and potassium increase inter alia the stickiness of carryover deposits and dust particles to the recovery boiler tubes, which accelerate fouling, corrosion and plugging of the recovery boiler. As the environmental legislation becomes more stringent, the degree of system closure increases. The present invention relates to a process by which the collected precipitator dust (1) is leached (2), at a temperature exceeding 50 DEG C, for a residence time sufficient to get a chloride and potassium enriched leach solution (4) and to remove at least a part of the content of metal ions in a solid phase (3). Said leach solution is electrochemically treated (5), preferably in an electrodialysis cell, in order to remove at least a part of the chloride and potassium therein. By the present process, the problem of sticky deposits in the recovery boiler can be substantially reduced. This means an improved energy efficiency as well as a higher degree of recovery of the pulping and bleaching chemicals.
Patent AU-595219-B2 (AU)
Title: Mono alkyl ethers of polyols, acrylates thereof, and radiation curable coating compositions containing the latter
Inventor: HIGBIE FRANCIS A
IPC: C09D171/00
Filed: 1986-07-22
Granted: 1990-03-29
Abstract: Radiation curable compositions containing outstanding reactive diluents have been developed. The diluents are lower alkyl ether acrylates and methacrylates of particular alkoxylated and non-alkoxylated polyols. Examples are mono-methoxy trimethylolpropane diacrylate, mono-methoxy neopentyl glycol monoacrylate and mono-methoxy, ethoxylated neopentyl glycol monoacrylate having an average of about two moles of ethylene oxide.
Patent AU-631465-B2 (AU)
Title: New morpholine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
IPC: A61P9/08
Filed: 1990-11-05
Granted: 1992-11-26
Abstract: New morpholine compounds of the formula:   <IMAGE>   in which: X, bonded to the aromatic nucleus, represents halogen or trifluoromethyl and R' represents hydrogen, (C1-C5)alkyl optionally including a double bond, or aralkyl; in racemic and enantiomeric forms, and physiologically tolerable acid addition salts theroef. These compounds and their physiologically tolerable salts can be used therapeutically especially in the treatment of ischaemic syndromes and cerebral ageing.
Patent AU-601912-B2 (AU)
Title: Pyran derivatives
Inventor: BAYLES RICHARD WILLIAM
IPC: C07D487/04
Filed: 1986-12-12
Granted: 1990-09-20
Abstract: Compounds of formula I: <CHEM>  wherein:  R1 is hydrogen or alkyl; R2 is alkyl optionally substituted by one or more alkoxy groups or halogen atoms; X is a group of formula -0R3 wherein R3 is alkyl, cycloalkyl, or arylalkyl; or X is a group of formula -NHCVR4 wherein V is oxygen or sulphur, R4 is hydrogen, alkyl, cycloalkyl (which alkyl and cycloalkyl groups may be substituted), alkenyl, aryl, arylalkyl, amino, mono- or di-alkylamino or a group of the formula -OR5 wherein R5 is optionally substituted alkyl, aryl or arylalkyl; or X is a group of formula -NHSO2R4a wherein R4a is alkyl, aryl or a group of formula -CH2COR4b wherein R4b is alkyl or aryl; Y is optionally substituted alkoxy, cycloalkoxy, arylalkoxy or a group of formula -NR6R7 wherein R6 is hydrogen or alkyl and R7 is alkyl, cycloalkyl (which alkyl and cycloalkyl groups may be substituted), aryl or arylalkyl or R7 is a group of formula -COOR8 wherein R8 is alkyl are useful intermediates in the synthesis of beta-lactam antibiotics.
Patent AU-543049-B2 (AU)
Title: Catalytic polymerisation of olefins
Inventor: STAIGER GERHARD
IPC: C08F4/64
Filed: 1981-03-13
Granted: 1985-03-28
Abstract: 1. A process for the preparation of homopolymers and copolymers of C2 -C6 -alpha-monoolefins at from 20 to 160 degrees C under a pressure of from 1 to 100 bar by means of a Ziegler-Natta catalyst system comprising (1) a modified titanium component and (2) an aluminium alkyl of the formula  see diagramm : EP0036536,P8,F1  where X and Y are alkyl of not more than 8 carbon atoms and Z is alkyl of not more than 8 carbon atoms or chlorine, with the proviso that the atomic ratio of titanium from the modified titanium component (1) to aluminium from the aluminium alkyl (2) is from 1:0.1 to 1:500, wherein (a) the catalyst system contains, as a further component, (3) an ester component of the formula  see diagramm : EP0036536,P8,F2 where R**1 is C1 -C4 -alkoxy, C1 -C4 -alkyl or hydrogen, R**2 is C1 -C4 -alkyl, and n is an integer from 0 to 3, with the proviso that the molar ratio of aluminium alkyl (2) to ester component (3) is from 10:8 to 10:0.5, and (b) the modified titanium component (1) employed is a component which is obtained by a method wherein first of all (1.1) in a first stage, (1.1.1) 100 parts by volume of titanium tetrachloride are brought together with (1.1.2) from 1 to 20 parts by volume of a benzene derivative of the formula  see diagramm : EP0036536,P9,F1  where R**3 is hydrogen or C1 -C4 -alkyl, R**4 is hydrogen or chlorine, R**5 is hydrogen or chlorine, or R**4 and R**5 together are oxygen, o is an integer from 0 to 3, and p is an integer from 0 to 3, and the mixture is kept at from 30 to 100 degrees C until it is in the form of a homogeneous liquid, thereafter (1.2) in a second stage, (1.2.1) the liquid resulting from stage (1.1) is brought together with (1.2.2) a magnesium alcoholate in the form of particles having a diameter of from 0.05 to 5.0 mm, and having the formula Mg(OD)2 , where D is a monovalent C1 -C8 -hydrocarbon radical of saturated aliphatic character and/or aromatic character, with the proviso that the molar ratio of benzene derivative (1.1.2) from stage (1.1) to magnesium alcoholate (1.2.2) is from 1:12 to 1:1, the mixture is kept, with constant mixing, at from 40 to 180 degrees C, for from 0.2 to 4 hours, and the resulting solid is isolated, with the removal of the residual liquid phase, and finally (1.3) in a third stage, (1.3.1) 100 parts by weight of titanium tetrachloride are brought together with (1.3.2) from 0.2 to 100 parts by weight of the solid resulting from stage (1.2), with or without (1.3.3) up to 15 parts by weight of a benzene derivative of the type defined under (1.1.2), the mixture is kept, with constant mixing, at from 40 to 180 degrees C for from 0.1 to 5 hours, and the resulting solid, constituting the modified titanium component (1), is isolated, with the removal of the residual liquid phase.
Patent AU-640975-B2 (AU)
Title: A controlled release device, and method of preparation
Inventor: DERRIEU GUY
IPC: A01N25/34
Filed: 1990-12-28
Granted: 1993-09-09
Abstract: A device permitting the progressive and programmed release of one or more active substances or ingredients, characterised in that it can be obtained by:   (a) preparing a powder comprising a polymer or resin matrix in which there is at least one suitable plasticiser which is completely absorbed, by spraying the said preheated plasticiser hot onto the said matrix whose temperature is maintained, so as to saturate the said resin while plasticising it; (b) cooling the powder obtained in (a) to a temperature below 30 DEG C; (c) mixing the powder obtained in (b) with at least 5% of at least one carrier of the active ingredient, in the cold state; then   (d) adding the active ingredient(s); and (e) bringing the powder obtained in (d) into a suitable form, by any suitable means, which device releases the active ingredient uniformly and completely.   The said device can furthermore comprise a polymer sleeve which is impervious to the active ingredient(s) and partly covers the surface of the device. Preparation process for the said device, and applications to the preparation of pharmaceuticals which can be administered orally, to the preparation of pharmaceuticals which can be administered by contact with the skin, and to the preparation of anti-parasite collars.
Patent AU-729718-B2 (AU)
Title: Seam integrity in multiple layer/multiple seam press fabrics
Inventor: DAVENPORT FRANCIS L
IPC: B32B5/26
Filed: 1998-04-03
Granted: 2001-02-08
Abstract: An on-machine-seamable papermaker's fabric includes a first and a second base fabric, each of which is joinable into endless form with a seam. The first and second base fabrics are attached to one another by at least one layer of staple fiber batt entangled therethrough such that they are offset with respect to one another in a lengthwise direction when joined. As a consequence, seaming loops at one widthwise edge of the first base fabric coincide with a non-seam region of the second base fabric, and seaming loops at one widthwise edge of the second base fabric coincide with a non-seam region of the first base fabric. When joined into endless form, the first base fabric is an outer base fabric, and the second base fabric is an inner base fabric. At least one extra cross-machine-direction (CD) yarn is woven with at least two of the following: (a) the outer side of the seaming loops of at least one widthwise edge of the outer base fabric; (b) the inner side of the seaming loops of at least one widthwise edge of the outer base fabric; (c) the outer side of the seaming loops of at least one widthwise edge of the inner base fabric; and (d) the inner side of the seaming loops of at least one widthwise edge of the inner base fabric.
Patent AU-728220-B2 (AU)
Title: Methods for increasing the efficiency of recombinant AAV product
Inventor: SAMULSKI RICHARD J
IPC: C07K14/075
Filed: 1998-04-14
Granted: 2001-01-04
Abstract: The present invention relates to methods and compositions for increasing the production of high titre stocks of recombinant AAV (rAAV) through regulation of expression of the AAV REP and CAP proteins. The methods and compositions of the invention are based on the observation that the low level expression of the AAV REP protein increases the production of AAV viral capsid protein and efficiency of packaging resulting in production of higher titre recombinant viral stocks. The invention encompasses recombinant AAV vectors that direct the expression of AAV REP and CAP proteins and the use of such vectors for the production of novel stable cell lines capable of generating high titre rAAV vectors. The invention provides methods for regulating the expression of the AAV REP gene at the transcriptional and post-translational level. The methods and compositions of the invention can be used to produce high titre stocks of rAAV which can be used in gene therapy for the purpose of transferring genetic information into appropriate host cells for the management and correction of human diseases including inherited and acquired disorders.
Patent AU-681161-B2 (AU)
Title: Virtual private network
Inventor: LAUTENSCHLAGER WOLFGANG
IPC: H04Q3/62
Filed: 1994-08-18
Granted: 1997-08-21
Abstract: Prior art: A supralocal virtual private network (VPNET) is formed by a number of private branch exchanges (PBX2, PBX3) or individual sets (E10) which, if necessary, communicate via public dial-up connections. The setting-up of the dial-up connections is initiated by dialling a service (VPN). Technical problem: The entire supralocal private network (VPNET) should act like one network for callers (C) on the public network (PUBNET). Basic concept: The service supports the switching of calls both from inside and outside the private network (VPNET), but allocates different tariffing attributes to the connections. Solution: IN service which transfers both calls between private branch changes (PBX1, PBX2) of a private network (VPNET) and from outside by means of a private numbering plan but, in doing so, initiates different tariffing. Advantages:     - Uniform company call number. - The same call number when moving from the area of one private branch exchange to that of another one. - Uniform company numbering plan also valid for calls from outside.     <IMAGE>
Patent AU-579508-B2 (AU)
Title: Apparatus for exchanging winding frames and used at a winding station for printed products
Inventor: STAUBER HANS-ULRICH
IPC: B65H39/14
Filed: 1987-04-13
Granted: 1988-11-24
Abstract: At a winding station for printed products a mobile winding frame coupled with the winding station is to be removed and exchanged for a winding frame which is to be coupled in its stead with the winding station. For this purpose there is provided an entrainment carriage moveable along a substantially linear path of travel and which can be coupled with an associated one of the winding frames and selectively can be moved towards and away from the winding station. There is additionally provided for such winding frame removal and exchange operation a platform which can be moved into and laterally out of the linear path of travel of the entrainment carriage at the region of the winding station. This platform serves for the reception of an emptied winding frame. The platform is preferably constructed in the manner of a low or ground-near carriage which travels upon wheels.
Patent AU-686197-B2 (AU)
Title: Use of coumarins and carbostyrils as PLA2-inhibitors, new coumarins and carbostyrils, process for preparing the same and medicaments
Inventor: FRIEBE WALTER-GUNAR
IPC: C07D493/04
Filed: 1994-07-09
Granted: 1998-02-05
Abstract: PCT No. PCT/EP94/02251 Sec. 371 Date Mar. 14, 1996 Sec. 102(e) Date Mar. 14, 1996 PCT Filed Jul. 9, 1994 PCT Pub. No. WO95/02588 PCT Pub. Date Jan. 26, 1995Use of compounds of formula I    <IMAGE>  (I)  in which R1, R2, R3, R4, Y and Z have the meanings stated in the claims, tautomers thereof as well as their salts with non-toxic acids or bases for the production of pharmaceutical agents having an inhibitory action on PLA2 in addition to compounds of formula I in which X does not denote a valency and processes for the production thereof.
Patent AU-651575-B2 (AU)
Title: Liquid crystal display apparatus and driving method of such apparatus
Inventor: OKADA SHINJIRO
IPC: G02F1/133
Filed: 1991-04-09
Granted: 1994-07-28
Abstract: A liquid crystal display apparatus which has a display section in which a group of scan electrodes and a group of signal electrodes are arranged in a matrix shape and a ferroelectric liquid crystal having a bistability in the direction of an electric field is filled between both of said electrode groups and displays an image or information, comprising: means for sequentially writing gradation information from a pixel having a high threshold value on a scan line by a pulse to completely reset all of pixels on a selected scan electrode into a first stable state and one or a plurality of pulses subsequent to said reset pulse.
Patent AU-783922-B2 (AU)
Title: Use of compositions consisting of cationic compounds and proton donors for stabilising and/or isolating nucleic acids in or from micro-organisms such as prokaryots, fungi, protozoa or algae
Inventor: OELMULLER UWE
IPC: C07F9/54
Filed: 2001-06-26
Granted: 2005-12-22
Abstract: Composition (A) comprises specific cationic compound (I) and at least one proton donor (II). Composition (A) comprises specific cationic compound of formula (I) and at least one proton donor (II). Y +>R 1R 2R 3R 4 X -> (I) Y : nitrogen or phosphorus; R 1-R 4linear or branched 1-20C alkyl, 6-20C aryl or 6-26C aralkyl; and X : anion of a mono- or poly-basic (in)organic acid. Independent claims are also included for the following: (a) method for preparing (A); (b) diagnostic composition, and kit for stabilizing nucleic acid (NA), containing (A); and (c) mixture of NA-containing biological sample, (A) and optionally other auxiliaries.
Patent AU-598846-B2 (AU)
Title: Programmable machine system
Inventor: GILES ALAN FREDERICK
IPC: G05B19/05
Filed: 1987-07-10
Granted: 1990-07-05
Abstract: A programmable machine is provided with a programmed computer and a number of actuators, the operation of the latter being controlled by the computer in conformity with this computer program. The computer also includes an operating program which co-operates with a display device and a data input device for the input of instructions to the computer. The operating program responds to a sequence of the entered instructions displayed on the display device having a separate display field for each actuator or a group of actuators and enabling an operator to enter instructions with the data input device into each field to define the movement of the respective actuator and the relationship between actuators. The display device illustrates the operating sequence of the machine as a diagram. The operating program translates this information into a machine code program controlling the operation of the actuators.
Patent AU-598020-B2 (AU)
Title: Cosmetic composition
Inventor: STURMEY INGRID CAROLINE
IPC: A61K31/23
Filed: 1987-08-25
Granted: 1990-06-14
Abstract: A therapeutic composition for alleviating or preventing sun-induced desquamation comprises as active ingredients a C3 to C30 2-hydroxyalkanoic acid or an ester thereof together with a sunscreen active ingredient in a therapeutically acceptable vehicle. The active ingredients can also be used in the preparation of the composition for the treatment or prevention of this skin condition which can follow exposure to an excessive amount of sunlight.
Patent AU-612983-B2 (AU)
Title: Recombinant vaccine
Inventor: RAMSHAW IAN ALLISTER
IPC: C07K14/52
Filed: 1987-07-31
Granted: 1991-07-25
Abstract: A recombinant vaccine comprises a vaccine vector which incorporates a first nucleotide sequence capable of being expressed as all or a part of an antigenic polypeptide, together with a second nucleotide sequence capable of being expressed as all or a part of a lymphokine effective in enhancing the immune response to the antigenic polypeptide. The vaccine vectors include poxvirus, herpes virus or adenovirus, and the lymphokine may be an interleukin or gamma-interferon. The vaccine vector may express an antigenic polypeptide which is foreign to the host vector.
Patent AU-646260-B2 (AU)
Title: N-sulfonylbenzotriazole microbicides
Inventor: ACKERMANN PETER
IPC: A01N43/647
Filed: 1991-06-20
Granted: 1994-02-17
Abstract: Novel benzotriazolesulphonic acid derivatives of the formula <IMAGE>  in which:   R1 is hydrogen, halogen, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkoxy having at least two identical or different halogen atoms, furthermore CF3, nitro or the group N(R')R'' where R' and R'' independently of one another are C1-C4-alkyl; R2 is phenoxy or phenylthio, each of which is unsubstituted or monosubstituted to trisubstituted by halogen, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkoxy having at least two identical or different halogen atoms, furthermore substituted by cyano, nitro, C2-C4-alkenyl, C2-C4-alkynyl, phenyl, 2-phenylethynyl or a further phenoxy radical which is unsubstituted or substituted by halogen, C1-C4-alkyl and/or C1-C4-alkoxy; or R2 is the radical O-CH2-O; R3 is alkyl, aryl or aralkyl having not more than 14 atoms, these radicals being substituted by halogen, C1-C4-alkyl and/or nitro; including the position isomers of R1 and R2 if these substituents occupy position 5 or 6. The novel active substances have crop-protecting properties and are particularly suitable for protecting plants against attack by phytopathogenic microorganisms such as fungi, in particular Oomycetes.
Patent AU-644555-B2 (AU)
Title: Magnetic field therapy and apparatus
Inventor: MARKOLL RICHARD
IPC: A61N2/02
Filed: 1991-05-06
Granted: 1993-12-09
Abstract: The present invention relates to an apparatus for treating a body organ by applying a magnetic field by way of an annular coil (T) surrounding the body organ, wherein the apparatus comprises a horizontal transitional surface (14), supporting means for the body organ arranged within the opening of the coil and at least one track (26) arranged at a level below the supporting means for moving the coil and the supporting means relative to each other.
Patent AU-646673-B2 (AU)
Title: Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity
Inventor: PASTAN IRA
IPC: C07K14/54
Filed: 1991-05-10
Granted: 1994-03-03
Abstract: Improved Pseudomonas exotoxins of low animal toxicity and high cytocidal activity are described. Substitution of positively charged amino acid residues with an amino acid residue without a positive charge provides markedly changed exotoxins. Conjugation of the new exotoxins with suitable targeting agents provides cytocidal specificity for killing desired cellular entities.
Patent AU-549787-B2 (AU)
Title: Fuel injection pump
Inventor: BASTENHOF DIRK
IPC: F02M59/36
Filed: 1982-04-16
Granted: 1986-02-13
Abstract: Internal combustion engine fuel injection pump of the type comprising an injection piston having a head with a helical ramp and provided with a device for adjusting in time the beginning of the fuel injection delivery. The adjusting device comprises a valve for closing and opening a bypass passage adapted to connect the said admission chamber to a space communicating with the chamber filling fuel source, and a system for the control of the valve including a control device for closing the valve depending on the angular position of a rotary member of the engine, such as a crankshaft, and for opening the valve in response to a partial vacuum created in the admission chamber by the suction stroke of the injection piston.